Información de la revista
Compartir
Descargar PDF
Más opciones de artículo
Letter to the Editor
Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
Anticoagulantes orales de acción directa (ACOD) en pacientes con fibrilación auricular durante la pandemia de COVID-19
a School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia
b School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia
c School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom
d School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia
Contenido relacionado
Med Clin. 2022;159:e6210.1016/j.medcli.2022.06.002
Manuel Méndez Bailón, Javier Azaña Gómez, Luis Pérez Belmonte
Artículo
This article is available in English
Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
10.1016/j.medcli.2022.05.016Med Clin. 2022;159:e61